Research underlines the moral impermissibility of CGC/M unless medically necessary

Emphasizing children’s rights over their own bodies should play a key role in protecting them against genital cutting and modification, a new study says.

Nanoscope Therapeutics exhibits positive top-line Phase IIb results for MCO-010

Share this article MCO-010 raises the prospect of introducing another mechanism of action into the retinitis space. Credit: Kateryna Kon via Shutterstock. Nanoscope Therapeutics released

March 28, 2024

BridgeBio secures $1.25bn for genetic therapy development

Share this article The financing will expedite the launch of acoramidis for treating transthyretin amyloid cardiomyopathy. Credit: Olena Yakobchuk / Shutterstock.com. BridgeBio Pharma has secured

January 19, 2024

Celcuity teams up with Bayer for Phase Ib/II prostate cancer trial – Pharmaceutical Technology

Celcuity is planning a Phase Ib/II trial for its prostate cancer therapy. Credit: FatCamera via Getty Images. US-based Celcuity has announced a new clinical trial

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.